Eduardo
Izquierdo
ab,
Mireia
Casasampere
b,
Gemma
Fabriàs
bc,
José Luís
Abad
b,
Josefina
Casas
*bc and
Antonio
Delgado
*ab
aDepartment of Pharmacology, Toxicology and Medicinal Chemistry, Unit of Pharmaceutical Chemistry (Associated Unit to CSIC). Faculty of Pharmacy and Food Sciences. University of Barcelona (UB), Joan XXIII 27-31, 08028 Barcelona, Spain. E-mail: antonio.delgado@ub.edu
bResearch Unit on BioActive Molecules, Department of Biological Chemistry, Institute for Advanced Chemistry of Catalonia (IQAC-CSIC), Jordi Girona 18-26, 08034-Barcelona, Spain. E-mail: fina.casas@iqac.csic.es
cLiver and Digestive Diseases Networking Biomedical Research Centre (CIBEREHD), ISCIII, 28029 Madrid, Spain
First published on 23rd February 2021
The suitability as FRET probes of two bichromophoric 1-deoxydihydroceramides containing a labelled spisulosine derivative as a sphingoid base and two differently ω-labelled fluorescent palmitic acids has been evaluated. The ceramide synthase (CerS) catalyzed metabolic incorporation of ω-azido palmitic acid into the above labeled spisulosine to render the corresponding ω-azido 1-deoxyceramide has been studied in several cell lines. In addition, the strain-promoted click reaction between this ω-azido 1-deoxyceramide and suitable fluorophores has been optimized to render the target bichromophoric 1-deoxydihydroceramides. These results pave the way for the development of FRET-based assays as a new tool to study sphingolipid metabolism.
The intracellular levels of Cer are the result of the catabolic processes from higher SLs (sphingomyelin, glycosphingolipids and ceramide-1-phosphate), together with biosynthesis de novo by the N-acylation of dhSo with a variety of fatty acids (FA), prior to their desaturation by a specific desaturase (Des1) that introduces a C4(E) double bond into the sphingoid base. In this context, ceramide synthases (CerS) are a family of enzymes responsible for the N-acylation of dhSo (in the de novo pathway) or So (in the catabolic pathway) to form dhCer and Cer, respectively (Scheme 1).
Six isoforms of CerS have been identified in mammals, each one of them encoded by a unique gene (CerS1-6).10 CerS enzymes are expressed differently in various tissues11 and their levels of expression change during development, suggesting that populations of Cer with particular acyl chain lengths might be generated to meet the specific physiological needs of each tissue.12 Moreover, the nature of the acyl chains is a determinant of the biophysical properties of the resulting Cer and also the signaling pathways in which they participate.13 The development of modern lipidomic techniques14 has allowed determination of the relative abundance of the various Cer types in a range of biological contexts, and has provided some insight into the effect of the acyl chain composition on the physiological role of Cer.15 Given the importance of CerS activity in cell fate, we became interested in the development of new chemical probes16 towards this end. In a previous work, we reported on the use of 1-deoxydihydrosphingosine (doxdhSo, spisulosine or ES285) as a suitable probe for the profiling of CerS activity in intact cells.17 On the basis that 1-deoxysphingolipids (doxSLs) can be virtually considered as “dead-end” metabolites, due to the lack of the C1-OH group, we envisioned that a fluorescent probe derived from spisulosine, together with a suitable FA analogue, could be used to develop a FRET-based assay to monitor CerS activity.18
The affinity towards lipid phases, fluorescent properties and sensitivity to the polarity of the surrounding environment of the fluorophores NBD and Nile red (NR) has promoted the use of these groups in several biological applications related to the study of the cell membrane.19,20 Due to the existing overlap between the emission band of NBD and the absorption band of NR, these two fluorophores have also been incorporated into lipids as a donor–acceptor fluorophore pair to perform FRET experiments.21–24 More recently, 7-methoxycoumarin-3-carboxylate (MCC) has also been used as an alternative fluorophore partner for NBD in FRET experiments.25 In this case, however, NBD played the role of the acceptor fluorophore, whereas MCC was used as the donor. On this basis, we considered the NBD-labelled spisulosine RBM5-155 and the ω-azido palmitic acid (ωN3PA) as suitable CerS substrates for an ideal experiment design. A strained-promoted alkyne–azide cycloaddition (SPAAC) of the resulting doxdhCer RBM5-159 with a BCN-derived fluorescent dye (RBM5-142 (MCC) or RBM5-143 (NR)) should render the bichromophoric doxdhCer RBM5-160 or RBM5-161, respectively, whose FRET emission should correlate with CerS activity (Scheme 2).
In this paper, we wish to report on the synthesis and photochemical characterization of the above probes and reagents, their validation as CerS substrates and their suitability as FRET partners.18
The fluorophores required for the SPAAC click reactions were obtained from the modified ω-aminoalkyl MCC and NR derivatives RBM5-135 and RBM5-136, respectively, obtained as shown in Scheme 4.18
The clickable reagents RBM5-142 and RBM5-143 were synthesized by the condensation of RBM5-135 and RBM5-136, respectively, with the p-nitrophenyl carbonate RBM5-141, obtained by the reaction of commercial trans-9-hydroxymethyl[6.1.0]bicyclonon-4-yne (BCN-OH) with 4-nitrophenyl chloroformate.30 The corresponding bichromophoric click adducts RBM5-160 and RBM5-161 were prepared for their complete photochemical characterization and as standards for FRET studies (Scheme 5).
The intramolecular FRET efficiencies of compounds RBM5-160 and RBM5-161 were estimated in DMSO and EtOH, based on the loss of donor fluorescence in the presence of the acceptor. To this end, we compared the integrated fluorescence intensities (I), within the donor-specific wavelength interval, of the donor (D) compounds (RBM5-142 and RBM5-154) to those of the related donor + acceptor (DA) compounds (RBM5-160 and RBM5-161, respectively). The calculated FRET efficiency of the NBD/NR pair in RBM5-161 (ENBD/NR = 0.88–0.96) was higher than that of the MCC/NBD pair in RBM5-160 (EMCC/NBD = 0.56–0.88). For both fluorophore pairs, the FRET process was more efficient in EtOH than in DMSO and, in the case of the NBD/NR pair in RBM5-161, the two studied excitation wavelengths gave the same E value in EtOH (Table 1).
Compound | Solvent | λ ex (nm) | E |
---|---|---|---|
a FRET efficiencies (E) were calculated from the decrease of the donor emission (see Experimental section). | |||
RBM5-160 | DMSO | 340 | 0.56 |
EtOH | 340 | 0.86 | |
RBM5-161 | DMSO | 470 | 0.90 |
455 | 0.88 | ||
EtOH | 470 | 0.96 | |
455 | 0.96 |
Experiments in MeOH, EtOH and sodium acetate buffer (NaOAc 250 mM, NaCl 200 mM, 0.1% Triton X-100) also showed a remarkable enhancement of the emission at 625 nm (acceptor emission, λexc = 455 nm) in comparison with RBM5-159, together with an attenuation of the fluorescence emission at 535 nm (donor emission, λexc = 455 nm), in agreement with the formation of the desired cycloadduct RBM5-161 (Fig. S1†). The background emission of RBM5-143 at 625 nm observed at the donor excitation (λexc = 455 nm) is indicative of an excitation cross-talk (or acceptor excitation bleed-through, AEB), a phenomenon related to the overlap of the donor and acceptor absorption spectra. This phenomenon, together with the related emission cross-talk (or donor emission bleed-through, DEB), arising from the overlap of the donor and acceptor emission spectra32 must be carefully considered in the design of ratiometric experiments based on the development of the FRET effect. In contrast, ratiometric experiments based on FRET attenuation21,22,24 may benefit from the disappearance of these interferences. The experimental AEB and DEB calculated for RBM5-161 are listed in Table S4 and Fig. S2, S3.†
1H NMR (400 MHz, CDCl3) δ 8.83 (s, 1H), 8.76 (br s, 1H), 7.58 (d, J = 8.7 Hz, 1H), 6.93 (dd, J = 8.7, 2.4 Hz, 1H), 6.86 (d, J = 2.4 Hz, 1H), 4.69 (br s, 1H), 4.13 (d, J = 8.1 Hz, 2H), 3.91 (s, 3H), 3.44 (td, J = 7.1, 5.8 Hz, 2H), 3.20–3.12 (m, 2H), 2.34–2.15 (m, 6H), 1.67–1.24 (m, 11H), 0.99–0.86 (m, 2H).
13C NMR (101 MHz, CDCl3) δ 164.9, 162.1, 162.1, 156.9, 156.8, 148.3, 131.0, 115.0, 114.1, 112.6, 100.4, 99.0, 62.7, 56.2, 41.0, 39.7, 30.0, 29.5, 29.2, 26.7, 26.5, 21.6, 20.2, 18.0.
HRMS calcd for C28H35N2O6 ([M + H]+): 495.2490, found: 495.2496.
1H NMR (400 MHz, CDCl3) δ 8.21 (d, J = 8.7 Hz, 1H), 8.03 (d, J = 2.6 Hz, 1H), 7.60 (d, J = 9.0 Hz, 1H), 7.15 (dd, J = 8.7, 2.6 Hz, 1H), 6.65 (dd, J = 9.1, 2.7 Hz, 1H), 6.45 (d, J = 2.7 Hz, 1H), 6.29 (s, 1H), 4.70 (br s, 1H), 4.19–4.11 (m, 4H), 3.46 (q, J = 7.1 Hz, 5H), 3.25–3.15 (m, 2H), 2.34–2.16 (m, 6H), 1.90–1.82 (m, 2H), 1.67–1.30 (m, 10H), 1.26 (t, J = 7.0 Hz, 6H), 0.97–0.87 (m, 2H).
13C NMR (101 MHz, CDCl3) δ 183.4, 161.9, 156.9, 152.2, 150.9, 147.0, 140.3, 134.2, 131.2, 127.9, 125.7, 124.8, 118.4, 109.6, 106.7, 105.5, 99.0, 96.5, 68.3, 62.8, 45.2, 41.1, 30.1, 29.3, 29.2, 26.6, 25.9, 21.6, 20.2, 17.9, 12.8.
HRMS calcd for C37H44N3O5 ([M + H]+): 610.3275, found: 610.3279.
1H NMR (400 MHz, CDCl3) δ 5.81 (ddt, J = 16.9, 10.2, 6.7 Hz, 1H), 4.99 (dq, J = 17.1, 1.9 Hz, 1H), 4.93 (ddt, J = 10.2, 2.4, 1.4 Hz, 1H), 3.41 (t, J = 6.9 Hz, 2H), 2.08–2.00 (m, 2H), 1.85 (dt, J = 14.5, 7.0 Hz, 2H), 1.46–1.33 (m, 3H), 1.32–1.25 (m, 16H).
13C NMR (101 MHz, CDCl3) δ 139.4, 114.2, 34.2, 34.0, 33.0, 29.8, 29.8, 29.7, 29.7, 29.6, 29.3, 29.1, 28.9, 28.3.
1H NMR (400 MHz, CDCl3) (E isomer) δ 5.71 (dt, J = 14.6, 6.7 Hz, 1H), 5.42 (dt, J = 15.0, 7.5 Hz, 1H), 4.76 (br s, 1H), 4.11 (dd, J = 6.4, 3.0 Hz, 1H), 3.73–3.58 (m, 1H), 3.40 (t, J = 6.9 Hz, 2H), 2.09–1.96 (m, 2H), 1.85 (dt, J = 14.5, 6.9 Hz, 2H), 1.44 (s, 9H), 1.43–1.23 (m, 20H), 1.07 (d, J = 6.9 Hz, 3H).
13C NMR (101 MHz, CDCl3) (mixture of E/Z isomers) δ 156.1, 155.7, 134.2, 133.5, 129.4, 128.7, 125.6, 124.9, 79.4, 79.2, 75.4, 73.5, 51.0, 50.0, 37.3, 33.9, 33.4, 32.8, 32.6, 32.3, 29.6, 29.5, 29.5, 29.4, 29.2, 28.7, 28.4, 28.1, 15.2, 14.3.
[α]20D = −3.65 (c 1, CHCl3).
1H NMR (400 MHz, CDCl3) δ 4.74 (br s, 1H), 3.70–3.67 (m, 1H), 3.64 (td, J = 8.0, 7.2, 2.7 Hz, 1H), 3.41 (t, J = 6.9 Hz, 2H), 1.85 (dt, J = 14.5, 7.0 Hz, 2H), 1.71 (br s, 1H), 1.44 (s, 9H), 1.43–1.35 (m, 4H), 1.34–1.23 (m, 22H), 1.08 (d, J = 6.8 Hz, 3H).
13C NMR (101 MHz, CDCl3) δ 156.0, 79.6, 74.6, 50.8, 34.2, 33.6, 33.0, 29.8, 29.7, 29.6, 28.9, 28.6, 28.3, 26.2, 14.5.
HRMS calcd for C23H47BrNO3 ([M + H]+): 464.2734, 466.2713, found: 464.2729, 466.2718.
[α]20D = −4.13 (c 1, CHCl3).
1H NMR (400 MHz, CDCl3) δ 4.75 (s, 1H), 3.71–3.67 (m, 1H), 3.66–3.61 (m, 1H), 3.25 (t, J = 7.0 Hz, 2H), 1.75 (br s, 1H), 1.66–1.54 (m, 2H), 1.44 (s, 9H), 1.40–1.35 (m, 4H), 1.34–1.23 (m, 22H), 1.07 (d, J = 6.8 Hz, 3H).
13C NMR (101 MHz, CDCl3) δ 156.0, 79.6, 74.6, 51.6, 50.7, 33.6, 29.8, 29.8, 29.7, 29.7, 29.7, 29.7, 29.6, 29.3, 29.0, 28.5, 26.8, 26.2, 14.4.
HRMS calcd for C23H47N4O3 ([M + H]+): 427.3643, found: 427.3636.
1H NMR (400 MHz, CD3OD) δ 3.53–3.47 (m, 1H), 3.47–3.41 (m, 1H), 2.67 (t, J = 7.1 Hz, 2H), 1.53–1.46 (m, 4H), 1.44 (s, 9H), 1.30 (s, 24H), 1.08 (d, J = 6.6 Hz, 3H).
13C NMR (101 MHz, CD3OD) δ 157.8, 79.9, 75.3, 51.8, 42.3, 34.8, 33.0, 30.8, 30.7, 30.6, 28.8, 28.0, 27.1, 15.5.
HRMS calcd for C23H49N2O3 ([M + H]+): 401.3738, found: 401.3742.
1H NMR (400 MHz, CDCl3) δ 8.49 (d, J = 8.6 Hz, 1H), 6.31 (br s, 1H), 6.17 (d, J = 8.7 Hz, 1H), 4.75 (br s, 1H), 3.73–3.66 (m, 1H), 3.66–3.62 (m, 1H), 3.49 (ap q, J = 6.7 Hz, 2H), 1.86 (br s, 1H), 1.81 (dt, J = 14.9, 7.4 Hz, 2H), 1.53–1.44 (m, 2H), 1.44 (s, 9H), 1.41–1.35 (m, 4H), 1.33–1.23 (m, 20H), 1.07 (d, J = 6.8 Hz, 3H).
13C NMR (101 MHz, CDCl3) δ 156.0, 144.3, 144.2, 144.0, 136.7, 123.7, 98.6, 79.6, 74.6, 50.8, 44.2, 33.6, 29.8, 29.7, 29.7, 29.7, 29.6, 29.6, 29.5, 29.3, 28.6, 28.5, 27.0, 26.1, 14.5.
HRMS calcd for C29H50N5O6 ([M + H]+): 564.3756, found: 564.3761.
1H NMR (400 MHz, CD3OD) δ 8.52 (d, J = 8.7 Hz, 1H), 6.35 (d, J = 8.9 Hz, 1H), 3.75–3.65 (m, 1H), 3.53 (br s, 2H), 3.31–3.22 (m, 1H), 1.77 (app p, J = 7.4 Hz, 2H), 1.55–1.37 (m, 8H), 1.36–1.25 (m, 18H), 1.22 (d, J = 6.8 Hz, 3H).
13C NMR (101 MHz, CD3OD) δ 146.7, 145.8, 145.5, 138.6, 122.7, 99.6, 71.7, 52.6, 44.8, 34.0, 30.7, 30.6, 30.3, 29.2, 28.0, 27.0, 12.1.
HRMS calcd for C24H42N5O4 ([M + H]+): 464.3231, found: 464.3228.
1H NMR (400 MHz, CDCl3) δ 8.48 (d, J = 8.6 Hz, 1H), 6.49 (br s, 1H), 6.17 (d, J = 8.7 Hz, 1H), 5.81 (d, J = 7.9 Hz, 1H), 4.05–3.96 (m, 1H), 3.66–3.59 (m, 1H), 3.53–3.45 (m, 2H), 3.24 (t, J = 7.0 Hz, 2H), 2.51 (br s, 1H), 2.17 (t, J = 7.6 Hz, 2H), 1.80 (app p, J = 7.4 Hz, 2H), 1.69–1.53 (m, 4H), 1.49–1.20 (m, 48H), 1.09 (d, J = 6.8 Hz, 3H).
13C NMR (101 MHz, CDCl3) δ 173.4, 144.4, 144.1, 144.1, 136.7, 123.9, 98.6, 74.5, 51.6, 49.6, 44.2, 37.0, 33.7, 29.7, 29.7, 29.5, 29.5, 29.4, 29.3, 29.0, 28.6, 27.1, 26.8, 26.1, 25.9, 14.3.
HRMS calcd for C40H71N8O5 ([M + H]+): 743.5542, found: 743.5547.
1H NMR (400 MHz, DMSO-d6) (mixture of diastereomers) δ 9.54 (s, 1H), 8.81 (s, 1H), 8.63 (t, J = 5.7 Hz, 1H), 8.50 (d, J = 9.1 Hz, 1H), 7.90 (d, J = 8.7 Hz, 1H), 7.49 (d, J = 8.5 Hz, 1H), 7.14–7.04 (m, 2H), 7.04 (dd, J = 8.7, 2.3 Hz, 1H), 6.41 (d, J = 9.3 Hz, 1H), 4.47 (d, J = 6.1 Hz, 1H), 4.18 (t, J = 7.0 Hz, 2H), 4.07–3.96 (m, 2H), 3.89 (s, 3H), 3.66–3.58 (m, 1H), 3.50–3.39 (m, 2H), 3.34–3.26 (m, 2H), 3.26–3.17 (m, 1H), 2.99–2.88 (m, 4H), 2.77–2.61 (m, 2H), 2.15–2.05 (m, 3H), 2.01 (t, J = 7.3 Hz, 2H), 1.73–1.60 (m, 4H), 1.56–1.05 (m, 60H), 0.97 (d, J = 6.7 Hz, 3H), 0.94–0.82 (m, 2H).
HRMS calcd for C68H105N10O11 ([M + H]+): 1237.7959, found: 1237.7983.
1H NMR (400 MHz, DMSO-d6) (mixture of diastereomers) δ 9.53 (br s, 1H), 8.48 (d, J = 8.9 Hz, 1H), 8.03 (d, J = 8.6 Hz, 1H), 7.94 (d, J = 2.5 Hz, 1H), 7.64–7.59 (m, 1H), 7.49 (d, J = 8.6 Hz, 1H), 7.25 (dd, J = 8.7, 2.5 Hz, 1H), 7.10 (t, J = 5.7 Hz, 1H), 6.81 (d, J = 9.2 Hz, 1H), 6.64 (d, J = 2.4 Hz, 1H), 6.38 (d, J = 9.0 Hz, 1H), 6.18 (s, 1H), 4.47 (d, J = 6.1 Hz, 1H), 4.21–4.10 (m, 4H), 4.02 (d, J = 7.8 Hz, 2H), 3.67–3.57 (m, 1H), 3.50 (q, J = 7.0 Hz, 4H), 3.46–3.39 (m, 2H), 3.25–3.18 (m, 1H), 3.15–3.04 (m, 4H), 3.05–2.95 (m, 2H), 2.94–2.86 (m, 2H), 2.78–2.59 (m, 2H), 2.13–1.90 (m, 7H), 1.83–1.73 (m, 2H), 1.70–1.59 (m, 4H), 1.54–1.10 (m, 58H), 0.96 (d, J = 6.7 Hz, 3H), 0.93–0.82 (m, 2H).
HRMS calcd for C77H114N11O10 ([M + H]+): 1352.8745, found: 1352.8760.
Fluorescence emission spectra were recorded on a Photon Technology International (PTI) QuantaMaster fluorometer at room temperature. The excitation and emission monochromators were set at 0.5 mm, giving a spectral bandwidth of 2 nm (except for fluorescein and compounds RBM5-155 and RBM5-159, in which case the monochromators were set at 0.35 mm, giving a spectral bandwidth of 1.4 nm). The data interval was 1 nm and the integration time was 1 s. All measurements were carried out using a Hellma 1.5 mL PTFE-stoppered fluorescence quartz cuvette (4 clear windows) with a 1 cm path length.
Molar extinction coefficients (ε) were calculated according to Lambert–Beer's law from solutions at concentrations ranging between 0.25 and 25 μM in the appropriate solvent system (spectrophotometric grade solvents). The absorbance values at the λAbsmax were then plotted against the corresponding concentrations and adjusted to a linear regression function forced through the origin (i.e. the line was forced to intercept (0,0)) using GraphPad Prism version 7.00 for Windows (GraphPad Software Inc., La Jolla, USA). Only the absorbance values in the range between 0.05 and 1 were used. Since we used a 1 cm path length cuvette, ε equals the slope of the graph.
Fluorescence quantum yields were measured (ΦF) following the comparative method described by Resch-Genger and Rurack41 (IUPAC technical report). The integrated fluorescence intensity (i.e. the area under the curve of the emission spectrum) was plotted against the corresponding Abs value at the λex and adjusted to a linear regression function forced through the origin using GraphPad Prism version 7.00 for Windows (GraphPad Software Inc., La Jolla, CA, USA). Then, ΦF was calculated by using eqn (1), where the subscripts x and Std. denote sample and standard, respectively, Grad equals the slope of the plot of the integrated fluorescence intensity vs. absorbance at the λex and η is the refractive index of the solvent.
![]() | (1) |
Spectral overlap integrals (J(λ)) of the donor–acceptor pairs were calculated using the specific J(λ) calculator tool from a|e UV-Vis-IR Spectral Software version 2.2 for Windows from FluorTools. To calculate J(λ), a|e UV-Vis-IR Spectral Software uses eqn (2), where FD is the normalised donor emission spectrum, εA is the extinction coefficient spectrum of the acceptor, and λ is the wavelength.
![]() | (2) |
Förster radius (R0) of the two different donor–acceptor pairs were calculated by using eqn (3), where ΦD is the quantum yield of the donor, J(λ) is the spectral overlap integral, η is the refractive index of the solvent and κ is a constant that reflects the relative orientation of the excited donor's electric field and the acceptor's absorption dipole. For molecules in which the rotational diffusion of the dyes is faster than the donor's fluorescence lifetime, κ takes a value of 2/3.42R0 was expressed in Å.
R0 = 0.211 × [κ2 × ΦD × J(λ) × η−4]1/6 | (3) |
y = a1x1 + a2x2 | (4) |
The deconvolution regression was carried out forcing an intercept with the origin, thereby obtaining a fitted curve (xi,yi values), the values for the a1 and a2 coefficients and a fitting score (R-square and SE); the reference spectra of the individual components (x1 and x2) were then multiplied by the a1 and a2 coefficients to obtain the calculated spectra.
![]() | (5) |
![]() | (6) |
![]() | (7) |
Footnote |
† Electronic supplementary information (ESI) available: Calculated spectral overlap integrals and Förster critical distances (Table S1), photophysical properties of the monochromophoric compounds (Table S2), photophysical properties of the bichromophoric compounds (Table S3), and the NMR spectra of the synthesized compounds. See DOI: 10.1039/d1ob00113b |
This journal is © The Royal Society of Chemistry 2021 |